Multinational, Randomized, Double Blind, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 800 mg od Versus 10 Days Penicillin V 500 mg Tid in Adolescent and Adult Subjects Equal to or Over 13 Years With Streptococcus Pyogenes Tonsillitis/Pharyngitis.

Trial Profile

Multinational, Randomized, Double Blind, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 800 mg od Versus 10 Days Penicillin V 500 mg Tid in Adolescent and Adult Subjects Equal to or Over 13 Years With Streptococcus Pyogenes Tonsillitis/Pharyngitis.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 07 Jul 2009

At a glance

  • Drugs Phenoxymethylpenicillin; Telithromycin
  • Indications Pharyngitis; Streptococcal infections; Tonsillitis
  • Focus Therapeutic Use
  • Acronyms TELITAD
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jul 2009 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 08 Apr 2009 Planned end date was 1 Sep 2006 as reported by ClinicalTrials.gov.
    • 08 Apr 2009 Actual patient number (233) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top